Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death

BACKGROUND: Risks of antithrombotic switching is not investigated in elderly atrial fibrillation patients. OBJECTIVES: To investigate the effectiveness and safety of antithrombotic treatment and switching of antithrombotic treatment in elderly patients (aged 75 years or older) with atrial fibrillati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrlinder, Hanne, Orsini, Nicola, Modig, Karin, Wallén, Håkan, Gigante, Bruna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596606/
https://www.ncbi.nlm.nih.gov/pubmed/36313983
http://dx.doi.org/10.1002/rth2.12823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596606/
https://www.ncbi.nlm.nih.gov/pubmed/36313983
http://dx.doi.org/10.1002/rth2.12823

Ejemplares similares